Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin versus glimepiride for central blood pressure reduction in adults with type 2 diabetes mellitus
2016-001237-27Phase 4Active
- Sponsor
- Instituto Gallego de Medicina Vascular
- Start
- Jun 2016
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Instituto Gallego de Medicina Vascular. Started Jun 2016; status: active.
02
Drugs
dapagliflozinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-001237-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001237-27.